Skip to main content
Paxman AB logo

Paxman AB — Investor Relations & Filings

Ticker · PAX ISIN · SE0009806284 LEI · 549300OT2V7Q4IDX8X68 ST Manufacturing
Filings indexed 0 across all filing types
Latest filing no filings yet
Country SE Sweden
Listing ST PAX

About Paxman AB

https://paxman.se/

Paxman AB is a global leader in medical technology focused on chemotherapy side effect management. The company develops and supplies the PAXMAN Scalp Cooling System, a cryotherapy-based treatment designed to minimize hair loss (alopecia) for cancer patients undergoing cytostatic treatments. With a mission to improve the quality of life for patients, Paxman's technology is used in hospitals, clinics, and treatment centers worldwide. The company has installed thousands of systems in over 65 countries, supporting more than 100,000 patients. In 2025, Paxman announced a merger with Dignitana, another key provider of scalp cooling technology, to further strengthen its market position.

Recent filings

No filings indexed yet

We are still gathering filings for Paxman AB. .

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.